QLY Biotech Group Corp.
company.status.inactiveCIK 1787123fmd_05Q5R7MDJS15FGF1SW71SEP4C4Transportation, Communications, Electric, Gas and Sanitary Services · Transportation ServicesTemplate: Standard
Coverage: Nov 30, 2018 to Feb 28, 2023, 16 periods
Latest annual · FY2022
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- 0
- Net income
- (0)
- Free cash flow
- (0)
Latest quarter · Q2 FY2023
Millions- Total revenues
- 0
- Gross profit
- 0
- Net income
- (0)
QLY Biotech Group Corp. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2022 | FY2021 | Change | Source |
|---|---|---|---|---|
| Revenue | $0 | $4,000 | -100% | 10-K 2022-12-14 · proof |
| Gross profit | $0 | $2,600 | -100% | 10-K 2022-12-14 · proof |
| Operating income | $14,112 | $29,503 | -52.2% | 10-K 2022-12-14 · proof |
| Net income | -$14,112 | -$29,503 | 10-K 2022-12-14 · proof | |
| Cash from operating activities | -$14,210 | -$26,265 | 10-K 2022-12-14 · proof | |
| Total assets | $0 | $7,159 | -100% | 10-K 2022-12-14 · proof |
| Total liabilities | $0 | $13,122 | -100% | 10-K 2022-12-14 · proof |
| Cash and cash equivalents | $0 | $5,169 | -100% | 10-K 2022-12-14 · proof |
- What was QLY Biotech Group Corp.'s revenue in fiscal 2022?
- QLY Biotech Group Corp. reported revenue of $0 for fiscal 2022 (the year ended Aug 31, 2022), against $4,000 the year before (-100%). Source: the 10-K filed with the SEC on Dec 14, 2022. SEC
- What was QLY Biotech Group Corp.'s gross profit in fiscal 2022?
- QLY Biotech Group Corp. reported gross profit of $0 for fiscal 2022 (the year ended Aug 31, 2022), against $2,600 the year before (-100%). Source: the 10-K filed with the SEC on Dec 14, 2022. SEC
- What was QLY Biotech Group Corp.'s operating income in fiscal 2022?
- QLY Biotech Group Corp. reported operating income of $14,112 for fiscal 2022 (the year ended Aug 31, 2022), against $29,503 the year before (-52.2%). Source: the 10-K filed with the SEC on Dec 14, 2022. SEC
- What was QLY Biotech Group Corp.'s net income in fiscal 2022?
- QLY Biotech Group Corp. reported net income of -$14,112 for fiscal 2022 (the year ended Aug 31, 2022), against -$29,503 the year before. Source: the 10-K filed with the SEC on Dec 14, 2022. SEC
- What was QLY Biotech Group Corp.'s cash from operating activities in fiscal 2022?
- QLY Biotech Group Corp. reported cash from operating activities of -$14,210 for fiscal 2022 (the year ended Aug 31, 2022), against -$26,265 the year before. Source: the 10-K filed with the SEC on Dec 14, 2022. SEC
- What are QLY Biotech Group Corp.'s total assets?
- As of Aug 31, 2022, QLY Biotech Group Corp. reported total assets of $0, against $7,159 a year earlier (-100%). Source: the 10-K filed with the SEC on Dec 14, 2022. SEC
- What are QLY Biotech Group Corp.'s total liabilities?
- As of Aug 31, 2022, QLY Biotech Group Corp. reported total liabilities of $0, against $13,122 a year earlier (-100%). Source: the 10-K filed with the SEC on Dec 14, 2022. SEC
- What are QLY Biotech Group Corp.'s cash and cash equivalents?
- As of Aug 31, 2022, QLY Biotech Group Corp. reported cash and cash equivalents of $0, against $5,169 a year earlier (-100%). Source: the 10-K filed with the SEC on Dec 14, 2022. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1787123&period_type=annual&limit=5"Information only, not investment advice.